
Health In Tech, Inc.
Health In Tech, Inc. (HIT) Free Cash Flow & Analysis
Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.
HIT · free cash flow · updated Jun 8, 2026
Core FCF metrics
HIT · FCF · TTM · margin & CAGRFree cash flow was −$56,108 for FY2025 (fiscal year ending 2025-12-31), down 104.4% year-over-year The FCF margin was -0.2%.
Annual free cash flow history
Annual free cash flow data
FCF valuation metrics
HIT · P/FCF · FCF yield · FCF per shareHealth In Tech, Inc. (HIT) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.
FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.
Cash flow statement summary
HIT · cash flow statement · operating / investing / financingFor FY2025, Health In Tech, Inc. generated $3.1M in operating cash flow and spent 3M in capital expenditures, yielding −$0.1M in free cash flow.
For the complete Operating / Investing / Financing line-item breakdown:
View Full Cash Flow Statement →Free cash flow vs peers (Technology)
About Free Cash Flow & Methodology
Health In Tech, Inc. (HIT) reported free cash flow of −$56,108 for FY2025 (fiscal year ending 2025-12-31), down 104.4% year-over-year. The FCF margin was -0.2%.
Based on available data, Health In Tech, Inc. has maintained positive free cash flow for at least 2 fiscal year(s). FCF peaked at $1.3M in FY2024.
Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.
Frequently asked questions
HIT free cash flow · 8 questionsHealth In Tech, Inc. free cash flow was −$56,108 for FY2025, down 104.4% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$1.2M.
▸ Source: FMP /cash-flow-statement · US GAAP · Health In Tech, Inc. · Health In Tech, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026